562
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia

ORCID Icon, , ORCID Icon, ORCID Icon, , , ORCID Icon, , , & show all
Received 10 May 2023, Accepted 19 Dec 2023, Published online: 19 Mar 2024

References

  • Volkow ND, Koob GF, McLellan AT, Longo DL. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363–71. doi:10.1056/NEJMra1511480.
  • Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3:760–73. doi:10.1016/S2215-0366(16)00104-8.
  • Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217–38. doi:10.1038/npp.2009.110.
  • Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatry. 2020;87:44–53. doi:10.1016/j.biopsych.2019.05.023.
  • Wise RA, Koob GF. The development and maintenance of drug addiction. Neuropsychopharmacology. 2014;39:254–62. doi:10.1038/npp.2013.261.
  • George O, Koob GF, Vendruscolo LF. Negative reinforcement via motivational withdrawal is the driving force behind the transition to addiction. Psychopharmacol (Berl). 2014;231:3911–17. doi:10.1007/s00213-014-3623-1.
  • Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci. 2006;26:5894–900 . doi:10.1523/JNEUROSCI.0740-06.2006.
  • Koob GF. Negative reinforcement in drug addiction: the darkness within. Curr Opin Neurobiol. 2013;23:559–63. doi:10.1016/j.conb.2013.03.011.
  • Koob GF. Anhedonia, hyperkatifeia, and negative reinforcement in substance use disorders. In: Pizzagalli D, editor. Anhedonia: preclinical, translational, and clinical integration [internet]. Cham: Springer International Publishing; 2022 [accessed 2022 Dec 8]. p. 147–65. (Current Topics in Behavioral Neurosciences; vol. 58). doi:10.1007/7854_2021_288.
  • Koob GF, Powell P, White A. Addiction as a coping response: hyperkatifeia, deaths of despair, and COVID-19. Am J Psychiatry [Internet]. 2020 Nov 1 [accessed 2022 Sep 28];177:1031–37. doi:10.1176/appi.ajp.2020.20091375.
  • Koob GF, Dantzer R. Drug addiction: hyperkatifeia/negative reinforcement as a framework for medications development. Pharmacol Rev. 2021;73:163–201. doi:10.1124/pharmrev.120.000083.
  • Carcoba LM, Contreras AE, Cepeda-Benito A, Meagher MW. Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals. J Addict Dis [Internet]. 2011 Jul 1 [accessed 2023 Aug 5];30:258–70. doi:10.1080/10550887.2011.581985.
  • Shurman J, Koob GF, Gutstein HB. Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Med [Internet]. 2010 Jul [accessed 2022 Dec 8];11:1092–98. doi:10.1111/j.1526-4637.2010.00881.x.
  • Case A, Hansen E, Goforth H, Koob G. The dark side of opioids: the neurobiological cycle of pain, opioids, tapering, hyperkatifeia, and despair. A conversation with George Koob, NIH addictions director (VF201). J Pain Symptom Manage [Internet]. 2022 May [accessed 2022 Dec 8];63:840–41. doi:10.1016/j.jpainsymman.2022.02.317.
  • Hall OT, Entrup P, King A, Vilensky M, Bryan CJ, Teater J, Niedermier J, Kaplan CM, Turner JA, Gorka S, et al. Central sensitization in alcohol use disorder: correlates of pain, addiction and health-related quality of life. J Addict Dis [Internet]. 2023 Jul 22 [accessed 2023 Jul 22]:1–12. doi:10.1080/10550887.2023.2237396.
  • Apkarian AV, Neugebauer V, Koob G, Edwards S, Levine JD, Ferrari L, Egli M, Regunathan S. Neural mechanisms of pain and alcohol dependence. Pharmacol Biochem Behav. 2013;112:34–41.
  • Egli M, Koob GF, Edwards S. Alcohol dependence as a chronic pain disorder. Neurosci Biobehav Rev [Internet]. 2012 Nov [accessed 2022 Dec 8];36:2179–92. doi:10.1016/j.neubiorev.2012.07.010.
  • Koob GF, Dantzer R. Drug addiction: hyperkatifeia/negative reinforcement as a framework for medications development. Dantzer R, editor. Pharmacol Rev [Internet]. 2021 Jan 1 [accessed 2022 Dec 23];73:163–201. doi:10.1124/pharmrev.120.000083.
  • Patterson JT, Koob GF, Anderson RI. Understanding hyperkatifeia to inform treatment for alcohol use disorder: an assessment of the National Institute on Alcohol Abuse and Alcoholism Research Portfolio.Biol Psychiatry [Internet]. 2022 Jun 15 [accessed 2022 Dec 23];91:e53–e9. doi:10.1016/j.biopsych.2022.02.011.
  • Dijkstra BAG, Krabbe PFM, Riezebos TGM, van der Staak CPF, de Jong CAJ. Psychometric evaluation of the dutch version of the Subjective Opiate Withdrawal Scale (SOWS). Eur Addict Res [Internet]. 2007 [accessed 2023 Feb 6];13:81–88. doi:10.1159/000097937.
  • Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug Alcohol Depend. 2015;151:47–55. doi:10.1016/j.drugalcdep.2015.02.033.
  • Lopatko OV, White JM, Huber A, Ling W. Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine. Drug Alcohol Depend [Internet]. 2003 Apr 1 [accessed 2023 Mar 3];69:317–22. doi:10.1016/S0376-8716(02)00322-8.
  • Cohen AJ, Klett CJ, Ling W. Patient perspectives of opiate withdrawal. Drug Alcohol Depend. 1983;12:167–72. doi:10.1016/0376-8716(83)90041-8.
  • Martel MO, Jamison RN, Wasan AD, Edwards RR. The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis. Pain Med. 2014;15:1757–64. doi:10.1111/pme.12416.
  • Martel MO, Wasan AD, Jamison RN, Edwards R. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend. 2013;132:335–41. doi:10.1016/j.drugalcdep.2013.02.034.
  • Kneeland ET, Griffin ML, Taghian N, Weiss RD, McHugh RK. Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain. Am J Drug Alcohol Abuse. 2019;45:488–94. doi:10.1080/00952990.2019.1581793.
  • Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7:524. doi:10.1037/1040-3590.7.4.524.
  • Tapia MAS, Ponce EEO. Catastrophizing-quality of life and pain. Int J Recent Adv Multidiscip Res. 2020;7:5687–89.
  • Van Loey NE, Klein‐König I, De Jong AEE, Hofland HWC, Vandermeulen E, Engelhard IM. Catastrophizing, pain and traumatic stress symptoms following burns: a prospective study. Eur J Pain. 2018;22:1151–59. doi:10.1002/ejp.1203.
  • Seminowicz DA, Davis KD. Cortical responses to pain in healthy individuals depends on pain catastrophizing. Pain. 2006;120:297–306. doi:10.1016/j.pain.2005.11.008.
  • Keogh E, Asmundson GJ. Negative affectivity, catastrophizing, and anxiety sensitivity. Underst Treat Fear Pain. 2004;91:115.
  • Hazlett-Stevens H, Craske MG. The catastrophizing worry process in generalized anxiety disorder: a preliminary investigation of an analog population. Behav Cogn Psychother. 2003;31:387–401. doi:10.1017/S1352465803004016.
  • Granot M, Ferber SG. The roles of pain catastrophizing and anxiety in the prediction of postoperative pain intensity: a prospective study. Clin J Pain. 2005;21:439–45. doi:10.1097/01.ajp.0000135236.12705.2d.
  • Özdel K, Taymur I, Guriz SO, Tulaci RG, Kuru E, Turkcapar MH, Seedat S. Measuring cognitive errors using the cognitive distortions scale (CDS): psychometric properties in clinical and non-clinical samples. PLoS ONE [Internet]. 2014 Aug 29 [accessed 2023 Apr 24];9:e105956. doi:10.1371/journal.pone.0105956.
  • Mason CK, Mullins-Sweatt SN. Catastrophizing, negative affectivity, and borderline personality disorder. Personal Ment Health [Internet]. 2021 [accessed 2023 Apr 24];15:283–92. doi:10.1002/pmh.1520.
  • Garnefski N, Kraaij V, Spinhoven P. Negative life events, cognitive emotion regulation and emotional problems. Personal Individ Differ [Internet]. 2001 Jun 1 [accessed 2023 Apr 24];30:1311–27. doi:10.1016/S0191-8869(00)00113-6.
  • Garnefski N, Boon S, Kraaij V. Relationships between cognitive strategies of adolescents and depressive symptomatology across different types of life event. J Youth Adolesc [Internet]. 2003 Dec 1 [accessed 2023 Apr 24];32:401–08. doi:10.1023/A:1025994200559.
  • Garnefski N, Kraaij V, van Etten M. Specificity of relations between adolescents’ cognitive emotion regulation strategies and internalizing and externalizing psychopathology. J Adolesc [Internet]. 2005 Oct 1 [accessed 2023 Apr 24];28:619–31. doi:10.1016/j.adolescence.2004.12.009.
  • Garnefski N, Legerstee J, Kraaij V, Van den Kommer T, Teerds J. Cognitive coping strategies and symptoms of depression and anxiety: a comparison between adolescents and adults. J Adolesc [Internet]. 2002 Dec 1 [accessed 2023 Apr 24];25:603–11. doi:10.1006/jado.2002.0507.
  • Garnefski N, Teerds J, Kraaij V, Legerstee J, van den Kommer T. Cognitive emotion regulation strategies and depressive symptoms: differences between males and females. Personal Individ Differ [Internet]. 2004 Jan 1 [accessed 2023 Apr 24];36:267–76. doi:10.1016/S0191-8869(03)00083-7.
  • Garnefski N, Van Den Kommer T, Kraaij V, Teerds J, Legerstee J, Onstein E. The relationship between cognitive emotion regulation strategies and emotional problems: comparison between a clinical and a non‐clinical sample. Eur J Personal [Internet]. 2002 Sep 1 [accessed 2023 Apr 24];16:403–20. doi:10.1002/per.458.
  • Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother [Internet]. 2009 May 1 [accessed 2023 Mar 3];9:745–58. doi:10.1586/ern.09.34.
  • Schütze R, Rees C, Smith A, Slater H, Campbell JM, O’Sullivan P. How can we best reduce pain catastrophizing in adults with chronic noncancer pain? A systematic review and meta-analysis. J Pain [Internet]. 2018 Mar 1 [accessed 2023 Mar 3];19:233–56. doi:10.1016/j.jpain.2017.09.010.
  • Enos G. Koob: understanding negative reinforcers of opioids could uncover new treatments. Alcohol Drug Abuse Wkly. 2019;31:1–7. doi:10.1002/adaw.32467.
  • Leung L. Pain catastrophizing: an updated review. Indian J Psychol Med. 2012;34:204–17. doi:10.4103/0253-7176.106012.
  • Wheeler CH, Williams ADC, Morley SJ. Meta-analysis of the psychometric properties of the pain catastrophizing scale and associations with participant characteristics. Pain. 2019;160:1946–53. doi:10.1097/j.pain.0000000000001494.
  • Neugebauer V, Li W, Bird GC, Han JS. The Amygdala and Persistent pain. Neuroscientist [Internet]. 2004 Jun 1 [accessed 2023 Aug 5];10:221–34. doi:10.1177/1073858403261077.
  • American Psychiatric Association D, Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. 2013. Washington: American Psychiatric Association Publishing.
  • Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
  • Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987;13:293–308. doi:10.3109/00952998709001515.
  • Pinedo González R, Palacios Picos A, de la Iglesia Gutiérrez M. “Surviving the violence, humiliation, and loneliness means getting high”: violence, loneliness, and Health of female sex workers. J Interpers Violence [Internet]. 2021 May 1 [accessed 2023 Apr 22];36:4593–614. doi:10.1177/0886260518789904.
  • Warf CW, Clark LF, Desai M, Rabinovitz SJ, Agahi G, Calvo R, Hoffmann J. Coming of age on the streets: survival sex among homeless young women in Hollywood. J Adolesc [Internet]. 2013 Dec 1 [accessed 2023 Mar 8];36:1205–13. doi:10.1016/j.adolescence.2013.08.013.
  • Syvertsen JL, Agot K, Ohaga S, Bazzi AR. You can’t do this job when you are sober: heroin use among female sex workers and the need for comprehensive drug treatment programming in Kenya. Drug Alcohol Depend [Internet]. 2019 Jan 1 [accessed 2023 Apr 22];194:495–99. doi:10.1016/j.drugalcdep.2018.10.019.
  • Sloss CM, Harper GW. When street sex workers are mothers. Arch Sex Behav. 2004;33:329–41. doi:10.1023/B:ASEB.0000028886.95568.2b.
  • Bennett T, Holloway K, Farrington D. The statistical association between drug misuse and crime: a meta-analysis. Aggress Violent Behav [Internet]. 2008 Mar 1 [accessed 2023 Apr 22];13:107–18. doi:10.1016/j.avb.2008.02.001.
  • Stenbacka M, Leifman A, Romelsjö A. Mortality and cause of death among 1705 illicit drug users: a 37 year follow up. Drug Alcohol Rev [Internet]. 2010 [accessed 2023 Apr 22];29:21–27. doi:10.1111/j.1465-3362.2009.00075.x.
  • Nolan NS, Marks LR, Liang SY, Durkin MJ. Medications for opioid use disorder associated with less against medical advice discharge among persons who inject drugs hospitalized with an invasive infection. J Addict Med [Internet]. 2021 Apr 1 [accessed 2023 Apr 22];15:155–58. doi:10.1097/ADM.0000000000000725.
  • Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study. Subst Abuse [Internet]. 2020 Oct 1 [accessed 2023 Apr 22];41:519–25. doi:10.1080/08897077.2019.1671942.
  • Hall OT, Teater J, Entrup P, Deaner M, Bryan C, Harte SE, Kaplan CM, Phan KL, Clauw DJ. Fibromyalgia predicts increased odds of pain-related addiction exacerbation among individuals with pain and opioid use disorder. Pain. 2022;164:1801–09. doi:10.1097/j.pain.0000000000002878.
  • Hall OT, Teater J, Rood K, Phan KL, Clauw DJ. Central sensitization in opioid use disorder: a novel application of the 2011 American College of Rheumatology Fibromyalgia survey. PAIN Reports; 2022.
  • Spadaro A, Long B, Koyfman A, Perrone J. Buprenorphine precipitated opioid withdrawal: prevention and management in the ED setting. Am J Emerg Med. 2022;58:22–26. doi:10.1016/j.ajem.2022.05.013.
  • Greenwald MK, Herring AA, Perrone J, Nelson LS, Azar P. A neuropharmacological model to explain buprenorphine induction challenges. Ann Emerg Med. 2022;80:509–524. doi:10.1016/j.annemergmed.2022.05.032.
  • Flora DB. Statistical methods for the social and behavioural sciences: a model-based approach. Stat Methods Soc Behav Sci. 2017;1–472.
  • Widaman KF. On common factor and principal component representations of data: implications for theory and for confirmatory replications. Struct Equ Model Multidiscip J. 2018;25:829–47. doi:10.1080/10705511.2018.1478730.
  • Briggs NE, MacCallum RC. Recovery of weak common factors by maximum likelihood and ordinary least squares estimation. Multivar Behav Res. 2003;38:25–56. doi:10.1207/S15327906MBR3801_2.
  • Velicer WF. Determining the number of components from the matrix of partial correlations. Psychometrika. 1976;41:321–27. doi:10.1007/BF02293557.
  • O’connor BP. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer’s MAP test. Behav Res Methods Instrum Comput. 2000;32:396–402. doi:10.3758/BF03200807.
  • Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30:179–85. doi:10.1007/BF02289447.
  • Cattell RB. The scree test for the number of factors. Multivar Behav Res. 1966;1:245–76. doi:10.1207/s15327906mbr0102_10.
  • Tataryn DJ, Wood JM, Gorsuch RL. Setting the value of k in promax: a monte carlo study. Educ Psychol Meas. 1999;59:384–91. doi:10.1177/00131649921969938.
  • Norman GR, Streiner DL. Biostatistics: the bare essentials. New Haven: PMPH USA (BC Decker); 2008.
  • Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. USA: Oxford University Press; 2015.
  • Sullivan MJ. The pain catastrophizing scale: user manual. Montr McGill Univ. 2009;1:36.
  • Larney S, Bohnert ASB, Ganoczy D, Ilgen MA, Hickman M, Blow FC, Degenhardt L. Mortality among older adults with opioid use disorders in the Veteran’s Health Administration, 2000–2011. Drug Alcohol Depend [Internet]. 2015 Feb 1 [accessed 2023 Mar 3];147:32–37. doi:10.1016/j.drugalcdep.2014.12.019.
  • Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, Bruneau J, Altice FL, Henderson G, Rahimi-Movaghar A, et al. Global patterns of opioid use and dependence: population harms, interventions, and future action. Lancet Lond Engl [Internet]. 2019 Oct 26 [accessed 2023 Mar 3];394:1560–79. doi:10.1016/S0140-6736(19)32229-9.
  • Blatt SJ, Rounsaville B, Eyre SL, Wilber C. The psychodynamics of opiate addiction. J Nerv Ment Dis. 1984;172:342–52. doi:10.1097/00005053-198406000-00005.
  • Manganiello JA. Opiate addiction: a study identifying three systematically related psychological correlates. Int J Addict. 1978;13:839–47. doi:10.3109/10826087809039307.
  • Nosrati E, Kang-Brown J, Ash M, McKee M, Marmot M, King LP. Economic decline, incarceration, and mortality from drug use disorders in the USA between 1983 and 2014: an observational analysis. Lancet Public Health. 2019;4:e326–e33. doi:10.1016/S2468-2667(19)30104-5.
  • Sugarman OK, Bachhuber MA, Wennerstrom A, Bruno T, Springgate BF. Interventions for incarcerated adults with opioid use disorder in the United States: a systematic review with a focus on social determinants of health. PLoS ONE [Internet]. 2020 Jan 21 [accessed 2023 Mar 3];15:e0227968. doi:10.1371/journal.pone.0227968.
  • Ti L, Ti L. Leaving the hospital against medical advice among people who use illicit drugs: a systematic review. Am J Public Health [Internet]. 2015 Dec [accessed 2023 Feb 20];105:e53–e9. doi:10.2105/AJPH.2015.302885.
  • Southern WN, Nahvi S, Arnsten JH. Increased risk of mortality and readmission among patients discharged against medical advice. Am J Med. 2012;125:594–602. doi:10.1016/j.amjmed.2011.12.017.
  • Abuse S. Key substance use and mental health indicators in the United States: results from the 2020 national survey on drug use and health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56); 2021.
  • O’Donnell J, Tanz LJ, Gladden RM, Davis NL, Bitting J. Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls — United States, 2019–2020. Morb Mortal Wkly Rep [Internet]. 2021 Dec 17 [accessed 2023 Mar 3];70:1740–46. doi:10.15585/mmwr.mm7050e3.
  • Hall OT, Hall OE, McGrath RP, Haile ZT. Years of life lost due to opioid overdose in Ohio: temporal and geographic patterns of excess mortality. J Addict Med [Internet]. 2020 Apr [accessed 2022 Jul 17];14:156–62. doi:10.1097/ADM.0000000000000554.
  • Hall OE, Trent Hall O, Eadie JL, Teater J, Gay J, Kim M, Cauchon D, Noonan RK. Street-drug lethality index: a novel methodology for predicting unintentional drug overdose fatalities in population research. Drug Alcohol Depend [Internet]. 2021 Apr 1 [accessed 2022 Jul 17];221:108637. doi:10.1016/j.drugalcdep.2021.108637.
  • Garcia S, Teater J, Trimble C, Entrup P, Hall OE, Hall OT. Years of life lost due to unintentional drug overdose relative to the leading underlying causes of death in the United States: a comparative analysis of excess mortality 2017–2019. J Addict Dis [Internet]. 2023 Mar 6 [accessed 2023 Mar 6];1–5. doi:10.1080/10550887.2023.2173929.
  • Antoine D, Huhn AS, Strain EC, Turner G, Jardot J, Hammond AS, Dunn KE. Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone. Am J Addict. 2021;30:83–87. doi:10.1111/ajad.13069.
  • NIH HEAL initiative [Internet]. Common Data Elements (CDEs) Program; 2021 [accessed 2023 Mar 3]. https://www.heal.nih.gov/data/common-data-elements
  • Koob GF. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology. 2009;56:18–31. doi:10.1016/j.neuropharm.2008.07.043.